Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,228
in 3 filings

Net −$43,228. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tamayo Louis Edward −$20K Chief Financial Officer sold 4% of stake
  2. Townsend Richard Nolan −$17K Chief Executive Officer sold <1% of stake
  3. Otero Jose Manuel −$6K Chief Operating Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2023-11-07 Longitude Capital Partners IV, LLC 10% owner Conversion +1,793,429 1,793,429
2023-11-07 Longitude Capital Partners IV, LLC 10% owner Conversion +319,126 2,112,555
2023-11-07 Longitude Capital Partners IV, LLC 10% owner Purchase +454,545 $11.00 $5.0M 2,567,100
2023-11-07 Longitude Capital Partners IV, LLC 10% owner Conversion · Series A convertible preferred stock −18,999,999 0
2023-11-07 Longitude Capital Partners IV, LLC 10% owner Conversion · Series B convertible preferred stock −2,906,148 0

Page 9 of 9 · 165 trades